Progress toward a group B streptococcal vaccine

Progress toward a group B streptococcal vaccine

Streptococcus agalactiae (group B Streptococcus, GBS) is a leading cause of severe invasive disease in neonate, elderly, and immunocompromised patients worldwide. Despite recent advances in the diagnosis and intrapartum antibiotic prophylaxis (IAP) of GBS infections, it remains one of the most commo...

Full description

Bibliographic Details
Main Authors: Joon Young Song, Jae Hyang Lim, Sangyong Lim, Zhi Yong, Ho Seong Seo
Format: Article
Language:English
Published: Taylor & Francis Group 2018-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
group b streptococcus
maternal immunization
streptococcus agalactiae
vaccine
Online Access:http://dx.doi.org/10.1080/21645515.2018.1493326

Internet

http://dx.doi.org/10.1080/21645515.2018.1493326

Similar Items